Search results
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks· 6 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
Research shows bulevirtide and peginterferon alfa-2a best treatment for chronic hepatitis D
Medical Xpress· 22 hours agoThe combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 5 days agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
CMDHD launches new hepatitis C treatment program
Midland Daily News· 1 day agoCentral Michigan District Health Department launched a new hepatitis C treatment program, aimed at providing accessible and effective treatment to individuals in the community ...
GSK acquires Elsie to unlock oligonucleotide therapeutics
Pharmaceutical Technology via Yahoo Finance· 4 days agoGSK chief scientific officer Tony Wood stated: “We have already made great strides in...
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
FierceBiotech· 6 days agoVir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase...
Two Philadelphia-area biotech firms report progress on pursuit of a hepatitis B cure - Philadelphia...
The Business Journals· 5 days agoTwo local life sciences companies reported progress this week on their efforts to develop a cure for...
Transgenic murine model expresses BCP-mutated hepatitis B virus genome
Medical Xpress· 6 days agoChronic hepatitis B virus (HBV) infection can lead to advanced liver pathology. HBV has been infecting humans for over 10,000 years, with coordinated viral gene expression to establish persistent infection.
How human-derived RNA fragments help the hepatitis E virus
Medical Xpress· 1 day agoRepeated sequencing of the virus RNA showed that the virus incorporated various parts of the host's messenger RNA into its genome. "The so-called insertion of host RNA can possibly predict the ...
Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D
MedPage Today· 6 days agoAt 24 weeks after the end of treatment, HDV RNA levels were undetectable in 46% of patients who...
